Warfarin

Head-to-head study compares tinzaparin and warfarin

Sunday, August 16th, 2015

A new head-to-head study from Canada has compared tinzaparin and warfarin for blood clot treatment among cancer patients. Tinzaparin is an injectable medication, while warfarin is an oral drug. Both treatment were effective in treatment, but tinzaparin was linked to a lower risk of bleeding as a side effect. A blood clot or venous thromboembolism […]

Obese patients may have greater bleeding risk with warfarin

Friday, May 15th, 2015

New research suggests that obese patients may have a greater risk of bleeding when they take warfarin, a commonly prescribed blood thinner. Patients are often prescribed warfarin after a heart attack or developing a blood clot. The study was led by Adedotun Ogunsua, an internal medicine resident at University of Massachusetts Medical School in Worcester, […]

Some anticoagulants may raise bleeding risk

Friday, May 1st, 2015

A new study comparing three anticoagulants has found that some of these blood thinners may raise the risk of bleeding. The medicines compared in this study were warfarin, rivaroxaban and dabigatran. Warfarin was found to have the lowest risk of bleeding, while dabigatran had the highest risk. The team was led by Hsien-Yen Chang, an […]

New device may provide anti-clotting medicine alternative for AF patients

Monday, November 17th, 2014

Warfarin and other blood thinners often require continuous monitoring to ensure that they are working properly. A new study, however, suggests that a device called LAA-closure device may prevent strokes and blood clots better than warfarin. The study was led by Vivek Y. Reddy, MD, of the Icahn School of Medicine at Mount Sinai, New […]

Dabigatran may cause more bleeding than warfarin

Sunday, November 9th, 2014

The US Food and Drug Administration (FDA) had approved the drug dabigratan in 2010 for stroke prevention, but a study have raised concerns that it may cause severe bleeding. The drug was approved after a trial indicating that it may be better than another popular blood-thinner, warfarin, for preventing strokes in patients diagnosed with atrial […]

Warfarin need not be discontinued before Pacemaker Surgery

Tuesday, May 14th, 2013

Researchers from the Bruise Control trial have recommended that patients not be stopped from taking warfarin in favor of heparin before a pacemaker surgery. Pacemakers, which are actually called implantable cardioverter-defibrillators (ICDs), are inserted for patients suffering from moderate to severe thromboembolism risk. The trial was conducted by David Birnie and colleagues from the University […]

tPA safe in patients using warfarin

Thursday, July 12th, 2012

A new study has found that treatment with tPA (tissue plasminogen activator) in stroke patients who take warfarin (Coumadin) is safe. The study was conducted by a group of researchers headed by Ying Xian, MD, PhD from the Duke Clinical Research Institute. The results of the study were published in the magazine “Journal of the […]

Low Doses of Warfarin may be Safe for Mothers and Babies

Tuesday, March 13th, 2012

A recently conducted pilot study reported that Warfarin, in low doses, might be safe for young women who have new-generation mechanical aortic valves. The study was conducted on 17 women who had the new valve and were taking a daily dosage of Warfarin 5mg or less. These women went on to deliver healthy babies by […]

Study suggests optimal warfarin dosing improves anticoagulation control.

Thursday, January 1st, 2009

 Study suggests optimal warfarin dosing improves anticoagulation control. Source:  DIA Daily HealthDay (12/30, McKeever) reported that “researchers now claim to have figured out the optimal dosing levels” for “preventing strokes and treating venous thromboembolism” with “the anticoagulant warfarin,” according to a study published in the December online issue of the Journal of Thrombosis and Haemostasis. […]